agm today, page-12

re: sbp long term trade PB , Paladin is the best example I can see to buy in cheap and hold, from less than one cent in 2003 to $2.61 in Sept 2005. After it had fallen from a peak of 24c in 1997. Congratulations if you rode it up.
I disagree that 10c is not a good buy on this stock.
No other Australian biotech has seen the results Coramsine has shown in their first Phase 1 . None. Please feel free to correct me on that point if I am wrong. During their phase 2 Novogen went up to nearly $9 and Progen to nearly $7. I know the biotech sector was more in favor then, but I think 8c is still very cheap with orphan drug granted by the FDA, and preparing to start Phase 2b trials on their target cancers.
Cheers